Patient and Provider Perspectives on Genetic Risk Profiling

Recruiting now

Conditions studied: Prostate Cancer

In brief

A qualitative interview study exploring the patient and provider perspectives on the clinical utility of genetic risk profiling in routine clinical practice. The findings from the study may contribute towards future research and informing clinical practice.

Key facts

Study ID

NCT07741929

Run by

Royal Marsden NHS Foundation Trust

People needed

40

Starts

2026-05-01

Expected to finish

2027-08-31

Last updated by the study team

2026-08-03

Who can join

Age: 18 and older, up to 100. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Individuals assigned male at birth who are aged 18 and over and who have capacity to consent
• Patients who have undergone genetic risk profiling for prostate cancer and have received their results
• Individuals from diverse backgrounds (age, ethnicity, risk status, etc)
• Healthcare providers who have delivered a genetic risk profiling result for prostate cancer

You may not qualify if…

• Individuals who lack capacity to consent
• Individuals deemed unsuitable to recruit based on their poor performance status or current medical condition

Where it is running

• The Royal Marsden Hospital (Sutton and Chelsea) — London, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.